Mesa Laboratories, Inc. MLAB
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 2.47% | 3.04% | 3.38% | 4.12% | 7.39% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.47% | 3.04% | 3.38% | 4.12% | 7.39% |
| Cost of Revenue | -4.72% | -2.14% | 2.23% | 7.87% | 11.48% |
| Gross Profit | 6.86% | 6.18% | 4.06% | 1.98% | 5.04% |
| SG&A Expenses | -0.45% | 0.72% | 3.86% | 5.22% | 5.10% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -2.19% | -0.36% | 3.23% | 6.05% | 7.76% |
| Operating Income | 73.86% | 57.48% | 5.37% | -16.26% | 2.07% |
| Income Before Tax | 84.56% | 3.16% | 101.54% | 105.21% | 102.73% |
| Income Tax Expenses | -23.81% | -52.98% | -33.18% | 150.68% | 144.10% |
| Earnings from Continuing Operations | 523.98% | 874.19% | 440.02% | 101.50% | 99.36% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 523.98% | 874.19% | 440.02% | 101.50% | 99.36% |
| EBIT | 73.86% | 57.48% | 5.37% | -16.26% | 2.07% |
| EBITDA | 22.53% | 15.64% | -0.74% | -3.76% | -4.26% |
| EPS Basic | 493.46% | 843.04% | 445.08% | 101.44% | 99.34% |
| Normalized Basic EPS | 80.15% | -4.12% | 174.54% | 223.28% | -15.32% |
| EPS Diluted | 458.85% | 711.01% | 426.96% | 101.39% | 99.30% |
| Normalized Diluted EPS | 80.13% | -3.67% | 174.64% | 224.01% | -16.17% |
| Average Basic Shares Outstanding | 2.44% | 2.29% | 1.73% | 1.46% | 1.15% |
| Average Diluted Shares Outstanding | 3.05% | 2.33% | 1.99% | 1.72% | 1.25% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | 1.24% | 1.13% | 1.30% | 68.71% | -157.03% |